Literature DB >> 27856827

Maximizing Health or Sufficient Capability in Economic Evaluation? A Methodological Experiment of Treatment for Drug Addiction.

Ilias Goranitis1, Joanna Coast2, Ed Day3,4, Alex Copello3,5, Nick Freemantle6, Emma Frew1.   

Abstract

Conventional practice within the United Kingdom and beyond is to conduct economic evaluations with "health" as evaluative space and "health maximization" as the decision-making rule. However, there is increasing recognition that this evaluative framework may not always be appropriate, and this is particularly the case within public health and social care contexts. This article presents a methodological case study designed to explore the impact of changing the evaluative space within an economic evaluation from health to capability well-being and the decision-making rule from health maximization to the maximization of sufficient capability. Capability well-being is an evaluative space grounded on Amartya Sen's capability approach and assesses well-being based on individuals' ability to do and be the things they value in life. Sufficient capability is an egalitarian approach to decision making that aims to ensure everyone in society achieves a normatively sufficient level of capability well-being. The case study is treatment for drug addiction, and the cost-effectiveness of 2 psychological interventions relative to usual care is assessed using data from a pilot trial. Analyses are undertaken from a health care and a government perspective. For the purpose of the study, quality-adjusted life years (measured using the EQ-5D-5L) and years of full capability equivalent and years of sufficient capability equivalent (both measured using the ICECAP-A [ICEpop CAPability measure for Adults]) are estimated. The study concludes that different evaluative spaces and decision-making rules have the potential to offer opposing treatment recommendations. The implications for policy makers are discussed.

Entities:  

Keywords:  ICECAP; capability; economic evaluation; health maximization; well-being

Mesh:

Year:  2016        PMID: 27856827     DOI: 10.1177/0272989X16678844

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  13 in total

1.  A head-to-head evaluation of the diagnostic efficacy and costs of trio versus singleton exome sequencing analysis.

Authors:  Tiong Yang Tan; Sebastian Lunke; Belinda Chong; Dean Phelan; Miriam Fanjul-Fernandez; Justine E Marum; Vanessa Siva Kumar; Zornitza Stark; Alison Yeung; Natasha J Brown; Chloe Stutterd; Martin B Delatycki; Simon Sadedin; Melissa Martyn; Ilias Goranitis; Natalie Thorne; Clara L Gaff; Susan M White
Journal:  Eur J Hum Genet       Date:  2019-07-18       Impact factor: 4.246

2.  An Investigation of the Overlap Between the ICECAP-A and Five Preference-Based Health-Related Quality of Life Instruments.

Authors:  Lidia Engel; Duncan Mortimer; Stirling Bryan; Scott A Lear; David G T Whitehurst
Journal:  Pharmacoeconomics       Date:  2017-07       Impact factor: 4.981

Review 3.  Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.

Authors:  Lidia Engel; Stirling Bryan; David G T Whitehurst
Journal:  Pharmacoeconomics       Date:  2021-08-23       Impact factor: 4.981

4.  Assessing the validity of the ICECAP-A capability measure for adults with depression.

Authors:  Paul Mark Mitchell; Hareth Al-Janabi; Sarah Byford; Willem Kuyken; Jeff Richardson; Angelo Iezzi; Joanna Coast
Journal:  BMC Psychiatry       Date:  2017-02-02       Impact factor: 3.630

5.  Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities?

Authors:  Paul Mark Mitchell; Sridhar Venkatapuram; Jeff Richardson; Angelo Iezzi; Joanna Coast
Journal:  Pharmacoeconomics       Date:  2017-06       Impact factor: 4.981

6.  Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP.

Authors:  Jasmine Peak; Ilias Goranitis; Ed Day; Alex Copello; Nick Freemantle; Emma Frew
Journal:  Health Qual Life Outcomes       Date:  2018-05-30       Impact factor: 3.186

Review 7.  Capability instruments in economic evaluations of health-related interventions: a comparative review of the literature.

Authors:  Timea Mariann Helter; Joanna Coast; Agata Łaszewska; Tanja Stamm; Judit Simon
Journal:  Qual Life Res       Date:  2019-12-24       Impact factor: 4.147

8.  Measuring broader wellbeing in mental health services: validity of the German language OxCAP-MH capability instrument.

Authors:  Agata Łaszewska; Markus Schwab; Eva Leutner; Marold Oberrauter; Georg Spiel; Judit Simon
Journal:  Qual Life Res       Date:  2019-04-27       Impact factor: 4.147

9.  A pilot feasibility randomised controlled trial of an adjunct brief social network intervention in opiate substitution treatment services.

Authors:  Ed Day; Alex Copello; Jennifer L Seddon; Marilyn Christie; Deborah Bamber; Charlotte Powell; Carmel Bennett; Shabana Akhtar; Sanju George; Andrew Ball; Emma Frew; Ilias Goranitis; Nick Freemantle
Journal:  BMC Psychiatry       Date:  2018-01-15       Impact factor: 3.630

10.  Comparing the measurement properties of the ICECAP-A and ICECAP-O instruments in ages 50-70: a cross-sectional study on a representative sample of the Hungarian general population.

Authors:  Petra Baji; Miklós Farkas; Ágota Dobos; Zsombor Zrubka; Levente Kovács; László Gulácsi; Márta Péntek
Journal:  Eur J Health Econ       Date:  2021-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.